Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
Related Questions
At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?
To what extent do you incorporate electrodiagnostic testing and ultrasonography in your clinical practice for evaluating suspected cases of meralgia paresthetica?
How do you approach maintenance immunosuppression in juvenile myasthenia gravis?
How do you identify patients with false positive AcHR antibodies?
What workup do you recommend for patients with symptoms suggestive of saphenous neuropathy?
How do you initiate steroids in ocular Myasthenia Gravis?
How do you counsel newly diagnosed patients with ALS on dietary recommendations?
How do you counsel anesthesia providers in perioperative management of patients with limb girdle muscular dystrophy?
How would one approach treating a patient with primary immunodeficiency on IVIG treatment who develops myasthenia gravis?
What testing do you order for patients with suspected dysautonomia?